Severe Asthma Study

Meridian is now conducting a clinical study for an investigational asthma medication for patients with Severe Eosinophilic Asthma. Asthma is usually characterized by chronic airway inflammation and symptoms of wheezing, shortness of breath, chest tightness and/or cough. The long-term goals of asthma management are to 1) achieve good symptom control, 2) minimize future risk of exacerbations, 3) minimize fixed airflow limitation and 4) minimize side-effects of treatment.

Eligible participants…

• Must be age 18 or older
• May receive compensation for time and travel
• Do not need insurance to join this study
• Must be nonsmokers, current smokers, or former smokers with a smoking history of <20 pack-years
• Must have been physician-diagnosed with asthma.
• Must be on high dose of Inhaled Corticosteroid (ICS) plus Long Acting Beta-Agonist (LABA) and Chronic Oral Corticosteroids (OCS) therapy for at least 6 months before Visit 1. The ICS and LABA can be contained within a combination product or given by separate inhalers.
• Have chronic OCS therapy equivalent to a daily dose of at least 5 mg of prednisone for at least 3 continuous months directly preceding Visit 1.

Eligible Participants Must NOT…

• Have clinically important pulmonary disease other than asthma or have ever been diagnosed with pulmonary or systemic diseases, other than asthma, that are associated with elevated peripheral eosinophil counts.
• Have experienced coincident primary adrenal failure (Addison’s disease) or irreversible secondary hypoadrenalism due to another independent cause (eg, pituitary tumor or its treatment).
• Have experienced coexistent inflammatory conditions for which chronic OCS doses are part of their maintenance treatment such as, but not limited, giant cell arteritis or polymyalgia rheumatica.

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.

Study Location

Meridian Clinical Research
5223 Paulsen Street
Savannah, GA 31405